What young men need to know about testicular cancer
By Jennifer O'Hara
While testicular cancer is rare compared with other types of cancer, it is the most common cancer in American males ages 15 to 35. Testicular cancer is highly treatable, even when cancer has spread beyond the testicle. Several treatments or a combination of treatments are available, and long-term survival rates are greater than 90%.
In this "Mayo Clinic Q&A" podcast video, Dr. Matthew Ziegelmann, a Mayo Clinic urologist, discusses diagnosis and treatment of testicular cancer:
A version of this article was originally published on the Mayo Clinic News Network.
Learn more about testicular cancer and find a testicular cancer clinical trial at Mayo Clinic.
Usually diagnosed between the ages of 15 and 45, testicular cancer is the most common solid tumor cancer diagnosed in young men.
Urologist and oncologist Dr. Timothy Lyon explains what men should know about testicular cancer.
Using advanced technology, scientists at Mayo Clinic, Chan Zuckerberg (CZ) Biohub and the University of California San Francisco (UCSF), have discovered an autoimmune disease that ...